mabcure inc (MBCI:OTC US)

Executive Profile*

Background*

Dr. Charles T. Tackney served as the Chief Scientific Officer of MabCure, Inc. since November 30, 2010. Dr. Tackney served as the Chief Scientific Officer at NeuroMark Genomics, Inc. since 2009. From 1997 through 2008, Dr. Tackney worked in various positions for the Ortho Clinical Diagnostics unit of Johnson & Johnson, including, Director of Diagnostic Biomarker Evaluation Group; Scientific Director of Advanced Research & Technology Assessment World Wide;; Director of ... Prion Research Group; Hepatitis Director of Worldwide Marketing; Group Leader of Protein Engineering and Senior Scientist, Department of New Technology R&D. From 1994 through 1997, Dr. Tackney served as a consultant for Access BioResource. He has been a Director of MabCure, Inc. since August 28, 2012. From 1985 to 1994, Dr. Tackney served as the Director of the Department of Molecular Biology at ImClone Systems Inc. Dr. Tackney earned his PhD in molecular genetics from the City University of New York and was awarded a postdoctoral research fellowship from the Damon Runyon Foundation at Columbia University College of Physicians and Surgeons.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
MBCI:US	$0.01 USD	0.00

COMPETITOR COMPENSATION